Anna Moseley

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

Mikkael A. Sekeres, Megan Othus, Alan F. List et al. · Journal of Clinical Oncology · 2017 · 238 citations

Medicine, Oncology, Pharmacotherapy +15

Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials

Joseph M. Unger, Anna Moseley, Banu Symington et al. · JAMA Network Open · 2018 · 206 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

Joseph M. Unger, Anna Moseley, Christabel K. Cheung et al. · Journal of Clinical Oncology · 2021 · 145 citations · Full text

Public Health, Biostatistics, Oncology +17

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

N. Lynn Henry, Joseph M. Unger, Anne F. Schott et al. · Journal of Clinical Oncology · 2017 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +17

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230

Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips et al. · JNCI Journal of the National Cancer Institute · 2018 · 90 citations · Full text

Medicine, Endocrinology, Oncology +15